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BACKGROUND/PURPOSE: Primary human immunodeficiency virus type 1 (HIV-1) infection is often 
under-diagnosed because of its nonspecific presentations. Elevated aminotransferase levels is one of 
its clinical manifestations, but is infrequently reported in the literature. The objective of this study was 
to investigate cases of elevated aminotransferases as a manifestation of primary HIV-1 infection.
METHODS: A retrospective chart review from October 1990 to May 2009 of HIV-1 infected patients in a 
registered database at a tertiary hospital was conducted to identify patients diagnosed with primary HIV-1 
infection. An elevated aminotransferase level was broadly defined as above-normal values of alanine or 
aspartate aminotransferases. Acute hepatitis markers were determined using stored serum samples.
RESULTS: Twenty-three of the 827 (2.8%) patients were identified as having a primary HIV-1 infection. 
All were male, with a median age of 26 years (range, 19–77 years), and the majority were men who had sex 
with men (19/23, 82.6%). The most common clinical manifestations were fever (95.7%), elevated ami-
notransferases (65.2%), fatigue (47.8%), and pharyngitis (47.8%). The median CD4 lymphocyte count was 
374/μL (range, 109–674/μL) and the median log HIV viral load was 5.0 (range, 4.3–5.9). For the 15 pa-
tients with abnormal liver function tests, the median aspartate aminotransferase level was 112 U/L (range, 
62–969 U/L) and the median alanine aminotransferase level was 146 U/L (range, 42–1,110 U/L).
CONCLUSION: Elevated aminotransferases may be an initial manifestation of primary HIV infection 
and is more common than expected. Primary HIV-1 infection should be one of the differential diagnoses 
considered in young men presenting with unexplained, new-onset liver function impairment.
KEYWORDS: acute HIV-1 infection, acute retroviral syndrome, hepatitis, primary HIV-1 infection
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Introduction
Primary human immunodeficiency virus type-1 (HIV-1) 
infection has a broad clinical spectrum ranging from asymp-
tomatic seroconversion to symptomatic mononucleosis-
like syndrome, which is also referred to as acute HIV-1 
infection, or acute retroviral syndrome. According to the 
literature, the incidence of symptomatic illness ranges 
from 40% to 90%,1 and usually presents within 2–6 weeks 
after exposure and resolves within 1–2 weeks.2 The most 
common manifestations include fever, fatigue, rashes 
(usually maculopapular), headache, lymphadenopathy, 
pharyngitis, myalgia, arthralgia, aseptic meningitis, retro-
orbital pain, weight loss, depression, gastrointestinal dis-
tress, night sweats, and oral or genital ulcers.1–4 During 
this period, the infected individual often has a very high 
viral load but maintains high-risk behavior, such as un-
protected sex and intravenous drug use with shared nee-
dles. From a public health point of view, early recognition 
and diagnosis of primary HIV-1 syndrome provides not 
only an opportunity for early treatment, but also for 
interruption of HIV-1 transmission.
Elevated aminotransferases is one of the characteristics 
of primary HIV-1 infection, or acute retroviral syndrome, 
with a frequency of 21% reported in the literature.1,3,4 In a 
case study from the National Taiwan University Hospital, 
10/20 patients (50%) had elevated hepatic enzymes.5 Case 
reports from the Cheng-Kung University Hospital found 
all three cases of primary HIV-1 infection to have elevated 
aminotransferases.6
Based on our clinical experience, elevated aminotrans-
ferases occur rather frequently in patients with primary 
HIV-1 infection. Our study aims to describe the clinical 
manifestations of primary HIV-1 infection in a tertiary 
hospital, to determine the frequency and to elucidate the 




A retrospective chart review of all patients diagnosed with 
HIV-1 infection in a registered database was conducted at 
Kaohsiung Veterans General Hospital, a tertiary hospital 
in Southern Taiwan, from October 1990 to May 2009, 
to identify subjects with primary HIV-1 infection. This 
included any of the following: (1) Patients clinically diag-
nosed as primary HIV-1 infection based on recent high-
risk behavior, relatively high viral loads and normal CD4 
counts, and compatible retroviral symptoms 3 months 
before serological positivity; (2) a positive enzyme immu-
noassay test for HIV-1 with indeterminate Western blot 
results (World Health Organization criteria), and two sep-
arate positive results for reverse transcriptase-polymerase 
chain reaction; or (3) negative serologic tests 6 months 
prior to symptoms compatible with primary HIV-1 infec-
tion, with positive HIV enzyme-linked immuno sorbent 
assay and Western blot results.7 The HIV-1 viral load was 
assessed using the Roche Cobas Amplicor HIV-1 monitor 
test (version 1.5) (Roche Branchburg, NJ, USA) and CD4 
count was done using the Beckman Coulter Cyto-stat/
Coulter Clone (Beckman Coulter, Fullerton, CA, USA).
Elevated aminotransferases was broadly defined as 
values of either alanine aminotransferase or aspartate ami-
notransferase above the upper normal limit. Acute hepati-
tis markers, including immunoglobulin M to hepatitis A 
virus (HAV-IgM), hepatitis B surface antigen (HBsAg), 
anti-hepatitis C virus (anti-HCV) antibody, antibody to 
early antigen of Epstein-Barr virus, immunoglobulin M 
to cytomegalovirus (CMV-IgM), and immunoglobulin G 
to cytomegalovirus (CMV-IgG) were also checked when 
stored serum or plasma samples were available.
Results
From October 1990 to May 2009, 23 patients with acute 
HIV-1 infection were identified after reviewing 827 HIV-1 
positive patients. All were male, with a median age of 
26 years (range, 19–77 years). The median CD4 count was 
374/μL (range, 109–674/μL) and the median log HIV-1 
viral load was 5.0 (range, 4.3–5.9). The major risk factors 
for HIV-1 infection were MSM (men who have sex with 
men; 82.6%) and heterosexual sex (13.1%). None were in-
travenous drug users. The most common clinical mani-
festations were fever (95.7%), elevated aminotransferases 
(65.2%), fatigue (47.8%), pharyngitis (47.8%), skin rashes 
(43.5%), and gastrointestinal symptoms (39.1%) (Table 1).
About two-thirds of the patients (15/23; 65.2%) had el-
evated aminotransferases, and 12/15 patients (80.0%) had 
serum or plasma samples available for further analysis. 
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Moreover, 6/15 patients (40.0%) had a paired serum sample 
taken 6 months later (Tables 2 and 3). All those tested were 
negative for HAV-IgM, HBsAg, and anti-HCV antibody. 
Anti body to early antigen of Epstein-Barr virus was nega-
tive in the first serum samples. Three cases were positive 
for IgM to CMV at low titer (1.42, 3.49 and 4.35, respec-
tively; cutoff = 0.8–1.1) and all were concomitantly posi-
tive for IgG to CMV. Aside from viruses, 4/15 (26.6%) had 
a positive Venereal Disease Research Laboratory test, with 
titers of 1:32, 1:16, 1:4, and 1:2, respectively.
Discussion
Primary HIV-1 infection was first reported in 1985 as a 
mononucleosis-like illness.3 Although 40–90% of patients 
present symptomatically, this syndrome is often underdiag-
nosed because of its nonspecific presentations.1 In a group 
of 23 people at risk of HIV-1 infection involved in routine 
surveillance programs with HIV-1 testing every 6 months, 
87% had symptomatic acute infection and 95% sought 
medical evaluation. Even with a high index of suspicion, 
only one-fourth were correctly diagnosed with primary 
HIV-1 infections on their first visit.7 Because of nonspecific 
presenting symptoms and signs, primary HIV-1 infection 
is frequently confused with a variety of other illnesses, such 
as infectious mononucleosis, secondary syphilis, acute hep-
atitis A or B, and other viral infections. Therefore, most of 
the literature related to primary HIV-1 infection focuses 
less on clinical symptoms, but more on diagnosis or prog-
nostic impact (Table 4). In our study, 23/827 (2.8%) HIV-1 
positive patients were identified as having a primary HIV-1 
infection. The reasons for such a low rate included the 
confusing symptoms of primary HIV-1 infection, clinical 
Table 1. Demographic data and clinical manifestations of 
patients with primary HIV-1 infectiona (n = 23)
Characteristics 
Age (yr) 26 (19–77)
Gender, male 23 (100)
CD4 count (/μL) 374 (109–674)
CD8 count (/μL) 989 (190–2,168)
Log10 HIV viral load (copies/mL) 5.0 (4.3–5.9)
Route of HIV transmission
 Men who have sex with men 19 (82.6)
 Heterosexual 3 (13.1)
 Unknown 1 (4.3)
Clinical manifestations (%)
 Fever 95.7
 Elevated aminotransferases 65.2
 Fatigue 47.8
 Pharyngitis 47.8
 Skin rash 43.5






 Aseptic meningitis 17.4
 Hepatosplenomegaly 13.0
 Oral thrush  8.7
aData presented as median (range) or n (%) or %.
Table 2. Biochemistry of patients with primary HIV-1 infec-
tion (n = 15)
Biochemistry Median (range)
AST (U/L) 112 (62–969)
ALT (U/L) 146 (42–1,110)
Total bilirubin (mg/dL) 0.8 (0.3–3.0)
AST = Aspartate amino transferases; ALT = alanine amino transferases.
Table 3. Acute hepatitis markers of patients with primary 
HIV-1 infection
Hepatitis marker First serum Paired serum
positivity (n = 12) (n = 6)
HAV-IgM 0 (0) 0 (0)
HBsAg 0 (0) 0 (0)
Anti-HCV Ab 0 (0) 0 (0)
EBV-EA Ab 0 (0) 0 (0)
CMV-IgMa 3 (25.0) NA
VDRL positiveb 4 (33.3) NA
aCMV IgM antibody: 1.42, 3.49 and 4.35 (cutoff = 0.8–1.1). All cases 
had a positive CMV-IgG titer. bVDRL titers: 1:32, 1:16, 1:4, 1:2. 
HAV-IgM = Immunoglobulin M to hepatitis A virus; HBsAg = hepati-
tis B surface antigen; anti-HCV Ab = anti-hepatitis C virus antibody; 
EBV-EA Ab = antibody against early antigen of Epstein–Barr virus; 
CMV-IgM = immunoglobulin M to cytomegalovirus; VDRL = Venereal 
Disease Research Laboratory; NA = not available.
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inattention of first-line clinicians, and poor serology 
detection tools for primary HIV-1 infection.
In the literature, abnormal liver function tests 
were seen in up to 21% of patients with primary HIV-1 
infection.1,3,4 However, the nature of the association be-
tween primary HIV-1 infection and hepatitis has not been 
described. The first case of acute hepatitis associated with 
primary HIV-1 infection was reported in 1992. The report 
described a young woman originating from Ghana who 
had an unexplained fever with abdominal pain and ab-
normal liver function tests. Despite intensive evaluation 
of hepatitis markers and even exploratory laparotomy, all 
of the results were negative. The symptoms spontaneously 
resolved after 1 week. Two years later, she was diagnosed 
with HIV-1 infection presenting with an opportunistic in-
fection. The original serum sample taken 2 years previ-
ously was retrospectively tested and was found to be positive 
for HIV-1.8
There have only been two reports describing the asso-
ciation between elevated aminotransferases and primary 
HIV-1 infection in Taiwan. In a case study from the Na-
tional Taiwan University Hospital, 10/20 of HIV-1 infected 
patients (50%) had elevated hepatic enzymes.5 Another 
case study from the Cheng-Kung University Hospital re-
ported three cases of primary HIV-1 infection, all of which 
had elevated aminotransferases.
Taiwan is a hyperendemic area for viral hepatitis, with 
HBV and HCV seroprevalences of 17.3% and 4.4%, respec-
tively.9 It is therefore necessary to screen the status of viral 
hepatitis in patients with naïve HIV-1 infection on their 
first visit, even those with initially normal liver function 
tests, and normal antibody levels to hepatitis A, HBsAg, 
surface and anti-core antibodies of hepatitis B, and anti-
hepatitis C. Patients with elevated aminotransferases should 
be further tested for HAV-IgM and HBV core IgM, and for 
viral loads of HCV.
In the current case study, elevated aminotransferases 
was the second most common clinical presentation, and 
present in two-thirds of patients, although none were se-
ropositive for HAV-IgM, HBsAg, and anti-HCV antibody. 
Three cases had low titer positivity for anti-CMV IgM, but 
the presence of this antibody in a single serum sample is 
insufficient for the diagnosis of a current primary infec-
tion. The reasons include: (1) IgM antibodies can persist 
for months after a primary infection, or reappear during 
recurrences;10 (2) a heterotypical immune response caused 
by inter-current infections;11 and (3) possible reactivation 
of a latent viral infection due to transient suppression of 
cellular immune functions.12 Because all three cases also 
had antibodies to CMV (IgM and IgG), the elevated he-
patic enzymes were less likely to be attributable to CMV 
infection.
Other than viruses, Treponema pallidum, the cause of 
syphilis, is known to cause diseases in every organ in the 
human body, including the liver. One case study reported 
seven cases of syphilitic hepatitis in HIV-1 infected patients, 
with a conspicuous increase in serum alkaline phospha-
tase level that resolved rapidly after effective antibiotic 
Table 4. Clinical symptoms and signs during primary HIV infection
 Niu et al2 HY Sun et al4 ST Huang et al5 Schacker et al7 
Sample size (n) 209 20 3 46
Sex, M/F – 20/0 3/0 43/3
Median age (yr) – 31 24 30
MSM transmissiona – 18 (90) 2 (67) 42 (91)
Top 3 Fever (96%)  Fever (95%) – Fever (93%)
symptoms/signs Adenopathy (74%)  Lymphadenopathy (75%)  Fatigue (89%)
 Pharyngitis (70%) Pharyngitis (70%)  Pharyngitis (70%)
 Rash (70%) Rash (70%)  
Abnormal liver  21 50 100 –
function tests (%)  
aData presented as n (%).
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treatment.13 In the current case study, four cases with ele-
vated aminotransferases also had a positive Venereal 
Disease Research Laboratory test. Three were tested for 
alkaline phosphatase, and all were within the normal 
range. One patient had previously been treated for syphi-
lis and did not show any symptoms associated with syphi-
lis. Only one patient underwent lumbar puncture to 
exclude neurosyphilis and received a standard 3-week 
penicillin treatment.
Because of the nonspecific presentation of primary 
HIV-1 infection and the relatively few clinical cases, this 
study has some limitations. First, it is a retrospective study, 
so the history of concurrent medications may be unreli-
able. Second, for those who met criterion one and were 
diagnosed with primary HIV-1 infection, the detuned test 
was not available to determine the timing of infection. 
Third, hepatitis was broadly defined as elevated hepatic 
aminotransferases and not based on histopathologic find-
ings. Nevertheless, invasive diagnosis using a liver biopsy 
for elevated aminotransferases that resolve spontaneously 
is not feasible in the clinical setting. Finally, serum samples 
were not available for further detailed tests, such as hepati-
tis C viral load or serial changes in serology titers. However, 
our study highlights the association between elevated ami-
notransferases and primary HIV-1 infection, and further 
prospective studies will allow more fully clarification of 
the nature of this association.
In conclusion, elevated aminotransferases may be one 
of the initial manifestations of primary HIV-1 infection 
and is probably more common than expected. Abnormal 
liver function tests may be related to HIV-1 infection, or 
to other concomitant viral or syphilitic hepatitis. Physi-
cians should have a high index of suspicion for the possi-
bility of primary HIV-1 infection when treating young 
males who present with unexplained, recent-onset liver 
function impairment. Aside from testing for other hepa-
totropic viruses, such as hepatitis A, B and C, detailed risk 
stratification of unprotected sex or intravenous drug use, 
and serological tests for HIV-1, should be conducted to 
enable diagnosis of primary HIV-1 infection, earlier man-
agement, and interruption of transmission.
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